FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s – The New York Times

July 1, 2024 by quixnet

FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’sThe New York Times
FDA approves a new Alzheimer’s drug from Eli LillyCNBC
FDA approves new Alzheimer’s treatment, donanemab from Eli LillyCBS News
Approval of Newest Alzheimer’s Drug Will Accelerate New Era of TreatmentThe Wall Street Journal